Tetratherix Limited

CHIA:TTX Stock Report

Market Cap: AU$387.7m

Tetratherix Valuation

Is TTX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of TTX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: TTX (A$7.26) is trading above our estimate of future cash flow value (A$0.06)

Significantly Below Future Cash Flow Value: TTX is trading above our estimate of future cash flow value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for TTX?

Key metric: As TTX barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for TTX. This is calculated by dividing TTX's market cap by their current book value.
What is TTX's PB Ratio?
PB Ratio11.8x
BookAU$32.73m
Market CapAU$387.69m

Price to Book Ratio vs Peers

How does TTX's PB Ratio compare to its peers?

The above table shows the PB ratio for TTX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average16.6x
PAR Paradigm Biopharmaceuticals
49.2x116.47%AU$161.8m
OCC Orthocell
5.7x73.05%AU$197.4m
CUV Clinuvel Pharmaceuticals
1.5x13.89%AU$411.5m
ACW Actinogen Medical
10.1x-62.16%AU$219.4m
TTX Tetratherix
11.8x25.74%AU$387.7m

Price-To-Book vs Peers: TTX is good value based on its Price-To-Book Ratio (11.8x) compared to the peer average (16x).

Historical Price to Book Ratio

Historical Price to Book Ratio compares a stock's price to the book value of it's equity over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Book Ratio vs Industry

How does TTX's PB Ratio compare vs other companies in the AU Biotechs Industry?

3 CompaniesPrice / BookEstimated GrowthMarket Cap
BNO Bionomics
0.3x-36.01%US$9.52m
CYV Ceryvyn Therapeutics
0.5x-113.03%US$9.87m
TRP Tissue Repair
0.6xn/aUS$3.49m
No more companies available in this PB range
TTX 11.8xIndustry Avg. 3.7xNo. of Companies6PB02.44.87.29.612+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: TTX is expensive based on its Price-To-Book Ratio (11.8x) compared to the Australian Biotechs industry average (3.8x).

Price to Book Ratio vs Fair Ratio

What is TTX's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

TTX PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio11.8x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate TTX's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst TTX forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentAU$7.26
AU$6.95
-4.23%
19.31%AU$8.59AU$5.30n/a3
Sep ’27AU$7.16
AU$6.95
-2.90%
19.31%AU$8.59AU$5.30n/a3
Aug ’27AU$7.54
AU$6.60
-12.44%
23.50%AU$8.59AU$4.80n/a3
Jul ’27AU$5.92
AU$6.12
+3.36%
16.02%AU$7.15AU$4.80n/a3
Jun ’27AU$7.14
AU$5.95
-16.65%
16.33%AU$6.84AU$4.60n/a3
May ’27AU$4.80
AU$5.72
+19.21%
19.61%AU$6.84AU$4.60n/a2
Apr ’27AU$4.12
AU$5.52
+33.91%
27.50%AU$7.03AU$4.00n/a2
Mar ’27AU$3.98
AU$4.88
+22.61%
18.03%AU$5.76AU$4.00n/a2
Feb ’27AU$3.98
AU$5.03
+26.38%
14.51%AU$5.76AU$4.30n/a2
Jan ’27AU$3.28
AU$5.03
+53.35%
14.51%AU$5.76AU$4.30n/a2
Dec ’26AU$4.11
AU$5.03
+22.38%
14.51%AU$5.76AU$4.30n/a2
Nov ’26AU$4.35
AU$5.03
+15.60%
14.49%AU$5.76AU$4.30n/a2
Oct ’26AU$4.16
AU$5.03
+20.88%
14.49%AU$5.76AU$4.30n/a2
Sep ’26AU$4.15
AU$5.03
+21.17%
14.49%AU$5.76AU$4.30AU$7.162
Aug ’26AU$5.00
AU$4.96
-0.77%
15.34%AU$5.72AU$4.20AU$7.542
AU$6.91
Fair Value
5.1% overvalued intrinsic discount
3
Number of Analysts

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/09 10:44
End of Day Share Price 2026/09/09 00:00
Earnings2026/06/30
Annual Earnings2026/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tetratherix Limited is covered by 2 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Melissa BensonBarrenjoey Markets Pty Limited
Scott PowerMorgans Financial Limited